Novartis Aktie
102,02
EUR
-0,64
EUR
-0,62
%
96,66
CHF
+0,07
CHF
+0,07
%
Werbung
Novartis Aktie Analyse
20.02.25 | Novartis Outperform | Bernstein Research | |
18.02.25 | Novartis Buy | Deutsche Bank AG | |
13.02.25 | Novartis Neutral | UBS AG | |
12.02.25 | Novartis Buy | Deutsche Bank AG | |
11.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
06.02.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
04.02.25 | Novartis Buy | Deutsche Bank AG | |
03.02.25 | Novartis Hold | Deutsche Bank AG | |
Werbung
|
|||
03.02.25 | Novartis Kaufen | DZ BANK | |
03.02.25 | Novartis Buy | UBS AG | |
31.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
31.01.25 | Novartis Buy | UBS AG | |
31.01.25 | Novartis Outperform | Bernstein Research | |
31.01.25 | Novartis Hold | Jefferies & Company Inc. | |
27.01.25 | Novartis Buy | UBS AG | |
20.01.25 | Novartis Hold | Jefferies & Company Inc. | |
09.01.25 | Novartis Neutral | Goldman Sachs Group Inc. | |
07.01.25 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
07.01.25 | Novartis Outperform | Bernstein Research | |
17.12.24 | Novartis Hold | Deutsche Bank AG | |
10.12.24 | Novartis Hold | Deutsche Bank AG | |
10.12.24 | Novartis Hold | Jefferies & Company Inc. | |
05.12.24 | Novartis Hold | Deutsche Bank AG | |
03.12.24 | Novartis Neutral | JP Morgan Chase & Co. | |
25.11.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
22.11.24 | Novartis Hold | Deutsche Bank AG | |
22.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.11.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
21.11.24 | Novartis Underweight | Barclays Capital | |
21.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
21.11.24 | Novartis Buy | UBS AG | |
20.11.24 | Novartis Hold | Deutsche Bank AG | |
14.11.24 | Novartis Buy | UBS AG | |
07.11.24 | Novartis Neutral | JP Morgan Chase & Co. | |
31.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
30.10.24 | Novartis Outperform | Bernstein Research | |
30.10.24 | Novartis Hold | Deutsche Bank AG | |
30.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
30.10.24 | Novartis Buy | UBS AG | |
29.10.24 | Novartis Outperform | Bernstein Research | |
29.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
29.10.24 | Novartis Buy | UBS AG | |
29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
08.10.24 | Novartis Hold | Deutsche Bank AG | |
02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
11.09.24 | Novartis Buy | UBS AG | |
05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Werbung
Werbung